Majority of complications from angioplasty occur within 18 hours

November 16, 2000

Researchers at Penn State College of Medicine in collaboration with several other universities have found that more than 80 percent of complications from angioplasty procedures occur within 18 hours of treatment.

"This is important information for hospitals that keep patients several days. They may not need to keep patients this long," says Ian Gilchrist, M.D., associate professor of medicine at Penn State College of Medicine and a cardiologist at the Penn State Milton S. Hershey Medical Center.

Gilchrist and his colleagues presented their work titled, "Temporal Spectrum of Ischemic Complications with Percutaneous Coronary Intervention: The ESPRIT Experience," Nov. 14 at the American Heart Association meeting in New Orleans. The research was conducted on data collected during a clinical trial testing the dose needed for an intravenous platelet inhibitor medicine.

"For years physicians would say there is about a 10 percent complication rate for angioplasty or stenting. We wanted to find out exactly when in those 30 days the problems occurred," he adds. Complications occurred in 178 patients in the trial and included heart attack, the need for additional surgery, or death. The researchers found that 82 percent of those complication occurred within 18 hours with most of these complications occurring right at the time of the procedure.

"We found that despite the use of stents or antiplatelet therapy, complications are still common with the procedure. Also, all of the patients enrolled in the trial had to be relatively stable, so the extremely ill patients did not even participate," says Gilchrist.

The ESPRIT trial is testing the dose needed for an intravenous platelet inhibitor medicine, called eptifibatide. The medication is designed to reduce blood clots that commonly cause complications during heart procedures. The study enrolled 2,064 patients.

Gilchrist adds future research needs to be focused on high- and low-risk subsets of patients to target early complications and focus the intensity and length of therapy based on the needs of the individual patient.

About 500,000 angioplasty procedures are performed each year in the United States to help people with heart disease.
-end-


Penn State

Related Angioplasty Articles from Brightsurf:

Ticagrelor was not superior to clopidogrel to reduce heart attack risk during angioplasty
A new study found the rate of heart attack and severe complications before, during or soon after elective surgery to open a blocked artery was similar between patients treated with clopidogrel and those who received the more potent antiplatelet medication ticagrelor.

Study finds significant variability in doctors' angioplasty death rates
Some doctors have higher or lower than expected death rates from coronary angioplasty procedures, also known as percutaneous coronary intervention (PCI); however, doctors should not be judged solely on the rate of patients who die from the procedure.

Beta-blockers following angioplasty show little benefit for some older patients
Following coronary angioplasty, beta-blockers did not significantly improve mortality rates or reduce the number of future cardiovascular incidents for older patients with stable angina but no history of heart attack or heart failure, according to a study published today in the JACC: Cardiovascular Interventions.

Sleep disorders may predict heart events after angioplasty
People who have had procedures to open blocked heart arteries after acute coronary syndrome (ACS) may have a higher risk of death, heart failure, heart attack and stroke if they have sleep disorders, such as sleep apnea, compared to those who don't.

Reasons for hospital-level variations in bleeding post-angioplasty are unclear
The use of bleeding avoidance strategies has only a modest effect on the variation in bleeding rates post-angioplasty among hospitals performing this procedure, leaving about 70 percent of the causes for this variation unexplained, according to a study published today in JACC: Cardiovascular Interventions.

US prediction models for kidney injury following angioplasty hold up in Japan
Models developed by the American College of Cardiology NCDR CathPCI Registry to predict the likelihood of angioplasty patients developing acute kidney injury and acute kidney injury requiring dialysis have proven to be effective among patients in Japan.

IV beta blockers before angioplasty are safe, but offer no clinical benefit
Giving intravenous beta blockers before performing a coronary angioplasty in patients who had experienced the deadliest form of heart attack -- ST-segment elevation myocardial infarction (STEMI) -- was safe but did not reduce heart attack severity or improve blood flow from the heart's main pumping chamber, according to research presented at the American College of Cardiology's 65th Annual Scientific Session.

Life-threatening bowel ischemia can often be treated by balloon angioplasty
Acute mesenteric ischemia (AMI) can be successfully treated with endovascular therapy such as balloon angioplasty, according to research from the University of Eastern Finland.

Radial access used less than femoral approach for emergency angioplasty
Although using the radial artery as the access point for angioplasty has been linked to reduced bleeding compared to use of the femoral artery, only a small number of high-risk heart attack patients who undergo rescue angioplasty -- emergency procedures following failed therapy with clot-busting drugs -- are treated by radial access, according to a study published today in the Journal of the American College of Cardiology: Cardiovascular Interventions.

Use of rarely appropriate angioplasty procedures declined sharply
The number of angioplasty procedures classified as rarely appropriate declined sharply between 2010 and 2014, as did the number of those performed on patients with non-acute conditions, according to a study published today in the Journal of the American Medical Association and simultaneously presented at a meeting of the American Heart Association in Orlando.

Read More: Angioplasty News and Angioplasty Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.